Pfizer (PFE) and BioNTech (BNTX) have halted recruitment for a large U.S.-based clinical trial designed to test their updated COVID-19 vaccine in healthy adults aged 50-64 years, citing challenges in ...
Pfizer (PFE) and BioNTech (BNTX) have halted recruitment for a large U.S.-based clinical trial designed to test their updated COVID-19 vaccine in healthy adults aged 50-64 years, citing challenges in ...
(Reuters) -Pfizer Inc said on Thursday it sold a part of its stake in German drugmaker BioNTech SE, more than five years after both firms formed an alliance that yielded a vaccine to combat the deadly ...
BioNTech CEO Ugur Sahin sold 149,500 shares under a June 10b5-1 plan as the company faces falling COVID revenue and key lung cancer data. BioNTech's Handover Year: Insider Selling, a Halved Revenue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results